US Patent Issued to Wyvern Pharmaceuticals on Dec. 2 for "Composition for regulating production of interfering ribonucleic acid" (Canadian Inventor)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,510, issued on Dec. 2, was assigned to Wyvern Pharmaceuticals Inc. (Calgary, Canada).

"Composition for regulating production of interfering ribonucleic acid" was invented by Bradley G. Thompson (Calgary, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Some embodiments of the present disclosure relate to one or more compositions that upregulate the production of one or more sequences of micro-interfering ribonucleic acid (miRNA). The miRNA may be complimentary to a sequence of target messenger RNA (mRNA) that encodes for a target biomolecule and the miRNA can cause the target mRNA to be degraded or inactivated, decreasing the bioavailability of ...